P Tsirigotis
Overview
Explore the profile of P Tsirigotis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
238
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Tsirigotis P, Triantafyllou K, Girkas K, Giannopoulou V, Ioannidou E, Chondropoulos S, et al.
Bone Marrow Transplant
. 2008 Jun;
42(5):337-43.
PMID: 18560408
Oral and/or intestinal mucositis is a severe complication of hematopoietic SCT. Keratinocyte growth factor (KGF) has proven activity in the prevention of oral mucositis. We examined the efficacy of KGF...
12.
Tsirigotis P, Sella T, Shapira M, Bitan M, Bloom A, Kiselgoff D, et al.
Haematologica
. 2007 Nov;
92(11):e106-10.
PMID: 18024386
Androgens widely used in the treatment of bone marrow failure syndromes can in rare cases cause hepatic peliosis, a pathological entity characterized by multiple blood-filled cavities in the liver parenchyma....
13.
Resnick I, Aker M, Tsirigotis P, Shapira M, Abdul-Hai A, Bitan M, et al.
Bone Marrow Transplant
. 2007 Sep;
40(10):957-64.
PMID: 17846604
The only radical cure for thalassemia major patients today is the replacement of the defective hematopoietic system by allogeneic stem cell transplantation (allo-SCT). The major obstacles for the application of...
14.
Tsirigotis P, Pappa V, Papageorgiou S, Kapsimali V, Giannopoulou V, Kaitsa I, et al.
Br J Dermatol
. 2007 Apr;
156(6):1379-81.
PMID: 17459033
No abstract available.
15.
Shapira M, Tsirigotis P, Resnick I, Or R, Abdul-Hai A, Slavin S
Crit Rev Oncol Hematol
. 2007 Feb;
64(1):49-63.
PMID: 17303434
The development of reduced intensity or non-myeloablative conditioning (NST) in preparation for allogeneic stem cell transplantation (SCT) revolutionized the field and led to reconsideration of the dogma of upper age...
16.
Or R, Hadar E, Bitan M, Resnick I, Aker M, Ackerstein A, et al.
Biol Blood Marrow Transplant
. 2006 Dec;
12(12):1295-301.
PMID: 17162211
The use of a mismatched allograft necessitates T cell depletion for prevention of uncontrolled graft-versus-host disease (GVHD), thus impairing a graft-versus-leukemia effect. Data on donor lymphocyte infusion (DLI) after mismatched...
17.
Miodosky M, Abdul-Hai A, Tsirigotis P, Or R, Bitan M, Resnick I, et al.
Bone Marrow Transplant
. 2006 Aug;
38(7):507-11.
PMID: 16921402
Hemorrhagic cystitis (HC) is a well-known complication of HSCT. Its overall incidence has been reported to vary from 7-68%. The spectrum of clinical presentation varies from asymptomatic microhematuria to life-threatening...
18.
Shapira M, Resnick I, Bitan M, Ackerstein A, Tsirigotis P, Gesundheit B, et al.
Bone Marrow Transplant
. 2005 Oct;
36(12):1097-101.
PMID: 16247429
We evaluated the effect of alefacept (Amevive), a novel dimeric fusion protein, in steroid resistant/dependent acute graft-versus-host-disease (aGVHD). Seven patients were treated in eight aGVHD episodes. GVHD grade at treatment...
19.
Pappa V, Papageorgiou S, Papageorgiou E, Panani A, Boutou E, Tsirigotis P, et al.
Leuk Res
. 2004 Dec;
29(2):229-31.
PMID: 15607373
P27 encodes a member of Cip/Kip family of cyclin dependent kinase inhibitors, the inactivation of which has been implicated in the pathogenesis of various hematological neoplasias. We report on a...
20.
Tsirigotis P, Economopoulos T, Rontogianni D, Dervenoulas J, Papageorgiou E, Bollas G, et al.
Oncology
. 2001 Nov;
61(4):257-64.
PMID: 11721171
Objectives: Clinical features, response to treatment and survival of T-cell-rich B-cell lymphoma (TCRBCL) patients were compared to those of a similar group of patients with diffuse large B-cell lymphoma (DLBCL)....